GlassScriptPhysician profile
Robert H Schmidt
NPI 1104993757
$2,021,735.00
in general payments reported to CMS, 2019-2025
16 companies · $3,631 in 2025
The $3,631 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187K · 2020: $283K · 2021: $392K · 2022: $673K · 2023: $446K · 2024: $36K · 2025: $3,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $407K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Consulting Fee: $8,959 · Food and Beverage: $2,618 · Travel and Lodging: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $407,210.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,325.00 |
| Consulting Fee | $8,958.86 |
| Food and Beverage | $2,617.55 |
| Travel and Lodging | $988.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,007,995.82 | 2019-2024 | Persona, M2a - Modular Head Hip System, Versys |
| Medical Device Business Services, INC. | $8,091.24 | 2019-2024 | Attune |
| Shalby Advanced Technologies, INC. | $3,419.10 | 2024-2025 | Cks - Vitalite, Consensus Knee System, Consensus Hip System |
| Depuy Synthes Sales INC. | $781.49 | 2021-2025 | Monovisc, Na |
| Stryker Corporation | $571.91 | 2019-2025 | Triathlon, Mako |
| Ferring Pharmaceuticals INC. | $319.62 | 2020-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $134.52 | 2020-2021 | |
| Microport Orthopedics INC | $96.61 | 2021-2022 | |
| Bioventus LLC | $95.30 | 2025 | Durolane |
| Smith+Nephew, INC. | $68.86 | 2025 | Pico 7 |
| Innovation Technologies INC | $48.63 | 2024-2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $41.20 | 2025 | |
| Davol INC. | $26.89 | 2025 | |
| Heron Therapeutics, INC. | $18.21 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.97 | 2024 | Caldolor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.